Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion.
To determine the role of various Na+ transport systems in the edema fluid accumulation after ischemia and reperfusion in the lung, we evaluated the effect of amiloride (a Na+ channel blocker), ouabain (a Na(+)-K(+)-adenosinetriphosphatase blocker), and phloridzin (a Na(+)-glucose cotransport blocker) in isolated rat lungs. Ischemia and reperfusion (I/R) significantly increased the edema accumulation, with the wet-to-dry weight ratios increasing to 10.14 +/- 0.58 from 6.03 +/- 0.05 in control lungs (P < 0.04). Amiloride significantly augmented the amount of edema fluid (wet-to-dry weight ratio 12.26 +/- 0.77), and ouabain further increased the amount of edema (wet-to-dry weight ratio 18.58 +/- 1.00). Phloridzin did not significantly affect edema formation associated with I/R. Isoproterenol decreased the amount of edema formation in the presence and absence of amiloride. This occurred because the endothelial permeability as assessed by filtration coefficient was restored to normal values and less edema formed. The present study indicates that Na+ channels and Na(+)-K(+)-adenosinetriphosphatase, components of the active Na+ absorption transport system, are very important in opposing edema fluid accumulation in rat lungs subjected to I/R injury and operate as an edema safety factor. However, if the endothelial damage associated with I/R is allowed to persist, then the transport processes, even if operative, are insufficient to prevent continuous edema accumulation.
Department of Physiology, College of Medicine, University of South Alabama, Mobile 36688.
P L
PL
Khimenko
J W
JW
Barnard
T M
TM
Moore
P S
PS
Wilson
S T
ST
Ballard
A E
AE
Taylor
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D002199:Capillary Permeability / Q000502:physiology*; D004848:Epithelium / Q000378:metabolism / Q000502:physiology; D066298:In Vitro Techniques; D007511:Ischemia / Q000503:physiopathology*; D008168:Lung / Q000098:blood supply* / Q000378:metabolism*; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D010695:Phlorhizin / Q000494:pharmacology; D011652:Pulmonary Circulation / Q000502:physiology*; D011654:Pulmonary Edema / Q000378:metabolism / Q000503:physiopathology*; D051381:Rats; D015424:Reperfusion; D012964:Sodium / Q000378:metabolism*; D015222:Sodium Channels / Q000187:drug effects
D015222:Sodium Channels; D010042:Ouabain; D000584:Amiloride; D012964:Sodium; D010695:Phlorhizin